Molecular and Cellular Biochemistry

, Volume 461, Issue 1–2, pp 127–139 | Cite as

Influence of signaling kinases on functional dynamics of nuclear receptor CAR

  • Ashutosh S. Yende
  • Rakesh K. TyagiEmail author


Constitutive androstane receptor (CAR) is a xenobiotic nuclear receptor known to regulate genes involved in key physiological processes like drug metabolism, maintenance of energy homeostasis, and cell proliferation. Owing to the diverse regulatory roles played by the receptor, it is critical to understand the precise cellular signals that dictate functional dynamics of CAR. With the objective of exploring the hitherto unknown regulatory pathways modulating CAR, we subjected the CAR protein sequence to a kinase prediction tool and identified several kinases recognizing CAR as a substrate. Using fluorescence live cell imaging and specific inhibitors it was observed that CAR functions under the regulation of mitogen-activated protein kinase (MAPK) and glycogen synthase kinase 3 (GSK3) signaling cascade. Additionally, insulin-like growth factor 1 (IGF1)-mediated inhibition of GSK3 also induced nuclear translocation of CAR linking CAR to the Akt signaling pathway. Identification of T38 residue of CAR as the GSK3 target site further substantiated our observations. Taking cues from these findings, we propose a hypothetical model elucidating the GSK3-mediated regulation of CAR dynamics through the involvement of Akt pathway. Further research into this area is expected to provide novel therapeutic targets in disease conditions like type 2 diabetes and hepatocellular carcinoma.


Constitutive androstane receptor Nuclear receptor Signaling kinase Glycogen synthase kinase 3 Akt 



The research work presented herein was financially supported by a research grant to RKT by National Agricultural Science Fund - Indian Council of Agricultural Research (F.No.NASF/ABA-7006/2018–2019) and University with Potential for Excellence - II (ID 25). Financial assistance to our Centre by Department of Science and Technology - Promotion of University Research and Scientific Excellence and University Grants Commission - Special Assistance Programme is duly acknowledged. Doctoral research fellowship to ASY by University Grants Commission - Jawaharlal Nehru University is acknowledged. We apologize to those of our colleagues whose significant contributions in the subject of this manuscript are not cited due to limited space.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Dash AK, Yende AS, Kumar S, Singh SK, Kotiya D, Rana M, Tyagi RK (2014) The constitutive androstane receptor (CAR): a nuclear receptor in health and disease. J Endocrinol Reprod 18(2):59–74Google Scholar
  2. 2.
    Chai SC, Lin W, Li Y, Chen T (2019) Drug discovery technologies to identify and characterize modulators of the pregnane X receptor and the constitutive androstane receptor. Drug Discov Today. CrossRefPubMedGoogle Scholar
  3. 3.
    Baes M, Gulick T, Choi HS, Martinoli MG, Simha D, Moore DD (1994) A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol 14(3):1544–1552CrossRefGoogle Scholar
  4. 4.
    Forman BM, Tzameli I, Choi HS, Chen J, Simha D, Seol W, Evans RM, Moore DD (1998) Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 395(6702):612–615. CrossRefPubMedGoogle Scholar
  5. 5.
    Yang H, Wang H (2014) Signaling control of the constitutive androstane receptor (CAR). Protein Cell 5(2):113–123. CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kawamoto T, Sueyoshi T, Zelko I, Moore R, Washburn K, Negishi M (1999) Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 19(9):6318–6322CrossRefGoogle Scholar
  7. 7.
    Gachon F, Olela FF, Schaad O, Descombes P, Schibler U (2006) The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. Cell Metab 4(1):25–36CrossRefGoogle Scholar
  8. 8.
    Mutoh S, Osabe M, Inoue K, Moore R, Pedersen L, Perera L, Rebolloso Y, Sueyoshi T, Negishi M (2009) Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). J Biol Chem 284(50):34785–34792. CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Saito K, Moore R, Negishi M (2013) p38 Mitogen-activated protein kinase regulates nuclear receptor CAR that activates the CYP2B6 gene. Drug Metab Dispos 41(6):1170–1173CrossRefGoogle Scholar
  10. 10.
    Yang H, Garzel B, Heyward S, Moeller T, Shapiro P, Wang H (2014) Metformin represses drug-induced expression of CYP2B6 by modulating the constitutive androstane receptor signaling. Mol Pharmacol 85(2):249–260. CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Woodgett JR (1991) cDNA cloning and properties of glycogen synthase kinase-3. Methods Enzymol 200:564–577CrossRefGoogle Scholar
  12. 12.
    Sutherland C (2011) What are the bona fide GSK3 substrates? Int J Alzheimers Dis 505607(10):18Google Scholar
  13. 13.
    Lochhead PA, Coghlan M, Rice SQ, Sutherland C (2001) Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression. Diabetes 50(5):937–946CrossRefGoogle Scholar
  14. 14.
    Liberman Z, Eldar-Finkelman H (2005) Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling. J Biol Chem 280(6):4422–4428CrossRefGoogle Scholar
  15. 15.
    Sakamaki J, Daitoku H, Kaneko Y, Hagiwara A, Ueno K, Fukamizu A (2012) GSK3beta regulates gluconeogenic gene expression through HNF4alpha and FOXO1. J Recept Signal Transduct Res 32(2):96–101CrossRefGoogle Scholar
  16. 16.
    Cline GW, Johnson K, Regittnig W, Perret P, Tozzo E, Xiao L, Damico C, Shulman GI (2002) Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51(10):2903–2910CrossRefGoogle Scholar
  17. 17.
    Dash AK, Yende AS, Tyagi RK (2017) Novel application of red fluorescent protein (DsRed-express) for the study of functional dynamics of nuclear receptors. J Fluoresc 27(4):1225–1231CrossRefGoogle Scholar
  18. 18.
    Kumar S, Chaturvedi NK, Nishi M, Kawata M, Tyagi RK (2004) Shuttling components of nuclear import machinery involved in nuclear translocation of steroid receptors exit nucleus via exportin-1/CRM-1* independent pathway. Biochim Biophys Acta 3:2–3Google Scholar
  19. 19.
    Xue Y, Liu Z, Cao J, Ma Q, Gao X, Wang Q, Jin C, Zhou Y, Wen L, Ren J (2011) GPS 2.1: enhanced prediction of kinase-specific phosphorylation sites with an algorithm of motif length selection. Protein Eng Des Sel 24(3):255–260CrossRefGoogle Scholar
  20. 20.
    Mutoh S, Sobhany M, Moore R, Perera L, Pedersen L, Sueyoshi T, Negishi M (2013) Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci Signal 6(274):ra31. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275(20):15122–15127. CrossRefPubMedGoogle Scholar
  22. 22.
    Kodama S, Koike C, Negishi M, Yamamoto Y (2004) Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol Cell Biol 24(18):7931–7940. CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Miao J, Fang S, Bae Y, Kemper JK (2006) Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the dr1 motif and to the common coactivators, GRIP-1 and PGC-1α. J Biol Chem 281(21):14537–14546. CrossRefPubMedGoogle Scholar
  24. 24.
    Ryves WJ, Dajani R, Pearl L, Harwood AJ (2002) Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites. Biochem Biophys Res Commun 290(3):967–972CrossRefGoogle Scholar
  25. 25.
    Ilouz R, Kaidanovich O, Gurwitz D, Eldar-Finkelman H (2002) Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem Biophys Res Commun 295(1):102–106CrossRefGoogle Scholar
  26. 26.
    Cross DA, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, Cohen P (1994) The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 303(Pt 1):21–26CrossRefGoogle Scholar
  27. 27.
    Shaw M, Cohen P, Alessi DR (1997) Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett 416(3):307–311. CrossRefPubMedGoogle Scholar
  28. 28.
    Fiol CJ, Williams JS, Chou CH, Wang QM, Roach PJ, Andrisani OM (1994) A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. J Biol Chem 269(51):32187–32193PubMedGoogle Scholar
  29. 29.
    ter Haar E, Coll JT, Austen DA, Hsiao HM, Swenson L, Jain J (2001) Structure of GSK3beta reveals a primed phosphorylation mechanism. Nat Struct Biol 8(7):593–596CrossRefGoogle Scholar
  30. 30.
    Corpet F (1988) Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 16(22):10881–10890CrossRefGoogle Scholar
  31. 31.
    Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, Moore JT (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 278(19):17277–17283. CrossRefPubMedGoogle Scholar
  32. 32.
    Kanno Y, Suzuki M, Nakahama T, Inouye Y (2005) Characterization of nuclear localization signals and cytoplasmic retention region in the nuclear receptor CAR. Biochim Biophys Acta 1745(2):215–222. CrossRefPubMedGoogle Scholar
  33. 33.
    Yamamoto Y, Moore R, Flavell RA, Lu B, Negishi M (2010) Nuclear receptor CAR represses TNFalpha-induced cell death by interacting with the anti-apoptotic GADD45B. PLoS ONE 5(4):0010121CrossRefGoogle Scholar
  34. 34.
    Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM (1998) Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase. J Biol Chem 273(29):18623–18632CrossRefGoogle Scholar
  35. 35.
    Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364(2):229–233CrossRefGoogle Scholar
  36. 36.
    Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Nat Acad Sci 98(24):13681–13686CrossRefGoogle Scholar
  37. 37.
    Ryves WJ, Harwood AJ (2001) Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 280(3):720–725CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Special Centre for Molecular Medicine, Jawaharlal Nehru UniversityNew DelhiIndia

Personalised recommendations